Emprime Therapeutics Inc.

Rochester, NY

UEI
W5XWZH1PDR39
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
601 Elmwood Ave, Rochester, NY 14642, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Emprime Therapeutics Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Full gene replacement for hemophilia a enabled by the stitchr technology - abstract hemophilia a (HA) is a common… Grant · R41HL180243 National Heart Lung and Blood Institute $314,363

Quick answers

What is Emprime Therapeutics Inc.'s UEI?

Emprime Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is W5XWZH1PDR39.

Where is Emprime Therapeutics Inc. located?

Emprime Therapeutics Inc.'s physical address in SAM.gov is 601 Elmwood Ave, Rochester, NY 14642, USA.

Is Emprime Therapeutics Inc. registered in SAM.gov?

Yes. Emprime Therapeutics Inc.'s SAM.gov registration is active through July 6, 2027.

What is Emprime Therapeutics Inc.'s most recent federal award?

Emprime Therapeutics Inc.'s most recent federal grant award is Full gene replacement for hemophilia a enabled by the stitchr technology - abstract hemophilia a (HA) is a common… (R41HL180243), from National Heart Lung and Blood Institute, on September 15, 2025.

On GovTribe

See Emprime Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login